Melon Health

Helping people help themselves

Shareholding: 24.9%
First Investment: December 2014

Melon Health’s digital self-management platform for chronic disease provides patients with the tools, support and information to help manage their condition and change behaviours. Melon’s customers are health care payers, insurers, pharmaceutical companies and health care delivery organisations in New Zealand, Australian and the United States. They include Primary Health Organisations, District Health Boards and the Ministry of Health in New Zealand, nib Australia, and Oscar Health and Georgia Physicians for Accountable Care in the United States. A 2015 trial for Midlands Health Network saw over 80% of pre-diabetes patients using Melon Health’s platform achieve a number of measurable, positive outcomes, with similar results after rollout.  Melon Health is based in Wellington with offices in the United States.

The last investment was the issue of a convertible note to Punakaiki Fund in August 2018. Prior to this, Punakaiki Fund also purchased a small parcel of existing shares from departing director and shareholder Brian Leighs. LWCM is active in the governance of Melon Health, with monthly board meetings, and a focus on strategic sales, financial management and accelerating growth.

Melon Health is close to closing a new funding round, led by Punakaiki Fund and with participation by two other investors. The timing of some of this investment is conditional upon the amount raised from this and (potentially) subsequent offers.

Recent News and Updates